Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†
W. Ray Kim(Mayo Clinic in Arizona), Henry C. Bodenheimer(Donaldson (United States)), Adrian M. Di Bisceglie(Saint Louis University), Steven L. Flamm(Northwestern University)
Cited by 865
Related Papers
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
|New England Journal of Medicine|2008|1.5k
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
|New England Journal of Medicine|2014|1.1k